|Articles|December 3, 2012

AHIP's Fall Forum 2012 Slideshow

Check out photos from America's Health Insurance Plans Fall Forum 2012. The meeting is being held at the Renaissance Hotel in Chicago, IL, from December 3-5.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Tobevibart Combo Shows High Hepatitis D Efficacy: Tarik Asselah, MD, PhD

ByBrooke McCormick,Tarik Asselah, MD, PhD

August 12th 2026

Fibrosis-Focused End Points Could Reshape MASH Trial Design: Zobair M. Younossi, MD

ByBrooke McCormick,Zobair M. Younossi, MD,Laura Joszt, MA

August 11th 2026

ALL Graphic | Image Credit: Sviatlana - stock.adobe.com

B-ALL Data Reinforce Push for Risk-Tailored Care

ByMaggie L. Shaw

July 30th 2026

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

ByBrooke McCormick,Xavier Leleu, MD, PhD

July 28th 2026

Leukemiaonwoodenblocks| Image Credit: © bo-stock.adobe.com

Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLL

ByMaggie L. Shaw

July 22nd 2026

AHIP's Fall Forum 2012 Slideshow

Related Content

Tobevibart Combo Shows High Hepatitis D Efficacy: Tarik Asselah, MD, PhD

Fibrosis-Focused End Points Could Reshape MASH Trial Design: Zobair M. Younossi, MD

B-ALL Data Reinforce Push for Risk-Tailored Care

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLL

Trending on AJMC

FDA Approves Novel Iberdomide Regimen in RRMM

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds

AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk

Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key